Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.24% |
| 2 | Financials | 6.69% |
| 3 | Healthcare | 6.46% |
| 4 | Industrials | 4.29% |
| 5 | Consumer Discretionary | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ametek
AME
$54.9B
| $111M | 0.06% |
831,401
-207,271
| -20% | -$27.8M |
|
302
PUT
Johnson & Johnson
JNJ
$651B
| $111M | 0.06% |
623,900
+201,200
| +48% | +$34.2M |
|
303
Qiagen
QGEN
$9.1B
| $110M | 0.06% |
2,121,844
+666,072
| +46% | +$34.4M |
|
304
Cooper Companies
COO
$14.9B
| $110M | 0.06% |
1,054,740
+568,528
| +117% | +$57.2M |
|
305
Automatic Data Processing
ADP
$112B
| $110M | 0.06% |
483,766
+26,717
| +6% | +$5.72M |
|
306
Semtech
SMTC
$11.6B
| $109M | 0.06% |
1,576,144
+810,202
| +106% | +$58.1M |
|
307
CALL
Citigroup
C
$221B
| $109M | 0.06% |
2,046,100
+145,300
| +8% | +$8.98M |
|
308
TransUnion
TRU
$16.2B
| $109M | 0.06% |
1,056,244
+1,044,066
| +8,573% | +$106M |
|
309
Dow Inc
DOW
$23.4B
| $109M | 0.06% |
1,704,567
-635,462
| -27% | -$38.3M |
|
310
Popular Inc
BPOP
$10.8B
| $108M | 0.06% |
1,319,280
+946,888
| +254% | +$83.7M |
|
311
Newmont
NEM
$139B
| $107M | 0.06% |
1,351,716
+902,010
| +201% | +$61M |
|
312
Teva Pharmaceuticals
TEVA
$43.5B
| $107M | 0.06% |
11,432,807
+8,752,890
| +327% | +$73M |
|
313
Boeing
BA
$169B
| $107M | 0.06% |
559,282
-129,498
| -19% | -$26M |
|
314
Accenture
ACN
$113B
| $106M | 0.06% |
313,168
+160,345
| +105% | +$54.1M |
|
|
FRC
315
DELISTED
First Republic Bank
FRC
| $105M | 0.06% |
650,424
+41,545
| +7% | +$7.25M |
|
316
Take-Two Interactive
TTWO
$44.8B
| $105M | 0.06% |
685,320
+152,698
| +29% | +$24.4M |
|
317
United Therapeutics
UTHR
$22B
| $105M | 0.06% |
583,798
+176,658
| +43% | +$33.7M |
|
318
General Dynamics
GD
$104B
| $105M | 0.06% |
434,080
+365,757
| +535% | +$81.2M |
|
319
Marvell Technology
MRVL
$213B
| $105M | 0.06% |
1,458,502
+1,181,440
| +426% | +$85.1M |
|
320
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $104M | 0.06% |
1,376,900
+691,500
| +101% | +$52.1M |
|
321
PUT
Procter & Gamble
PG
$336B
| $104M | 0.06% |
682,000
-362,800
| -35% | -$56.8M |
|
322
PUT
Gilead Sciences
GILD
$181B
| $104M | 0.06% |
1,751,200
-396,200
| -18% | -$25.3M |
|
323
Fortive
FTV
$18.1B
| $103M | 0.05% |
2,246,827
+2,141,483
| +2,033% | +$106M |
|
324
Kimberly-Clark
KMB
$36.4B
| $103M | 0.05% |
837,375
+782,257
| +1,419% | +$103M |
|
325
Camden Property Trust
CPT
$10.8B
| $103M | 0.05% |
618,834
+212,953
| +52% | +$35.1M |
|
Similar funds
Israel Englander's Q1 2022 Portfolio in Review
As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Israel Englander's Q1 2022 filing shows 1,492 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Israel Englander opened 1,492 new positions and closed 1,365 in Q1 2022.
- Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.